PharmacoEconomics

, Volume 20, Issue 3, pp 143–152 | Cite as

Optimising Drug Utilisation in Long Term Care

Review Article

Abstract

Providing quality long term care for the elderly while containing costs is presenting major challenges for governments and policy makers. Although international variability exists with respect to the number of medications and other factors influencing suboptimal pharmacotherapy, suboptimal pharmacotherapy among elderly persons is common. This international problem requires a creative and multifaceted approach to improve and rationalise prescribing.

We outline the non-regulatory efforts and regulatory means to approaching this problem. The recent introduction of a prospective payment system for long-term care in the US has underscored the importance of a regulatory approach to counter-balance the cost containment efforts which bundle the cost of medications into a prospectively set per diem rate. An examination of how US regulatory bodies are considering improving prescribing is provided. Considering the case of coronary heart disease, we provide data regarding the performance of a quality indicator aimed at stimulating quality prescribing for this medical condition. Although the use of regulatory approaches can improve prescribing, it is also recognised that a more holistic approach involving multidisciplinary teams and greater focus on the patient is the ultimate aspiration. This is particularly the case with the elderly in whom appropriate drug therapy can have a major impact on outcomes.

A major cultural shift in the way society views and treats the elderly may be required in order to produce dramatic improvements in long term care for older people.

Notes

Acknowledgements

The impetus for this paper stemmed from numerous lively conversations between the two authors while Dr. Hughes was a Harkness Fellow in Healthcare Policy 1998 to 1999. Dr Lapane is attempting to implement some of the ideas for improving pharmacotherapy in long term care in part by a contract (#500-95-0622) ‘Development and Validation of Quality Indicators’ from the Health Care Financing Administration (HCFA), to the Abt Associates with a subcontract to Brown University in Providence, Rhode Island, USA. Fellowship funding for Dr Hughes was provided by The Commonwealth Fund, a New York City-based private independent foundation. The views presented here are those of the authors and not necessarily those of The Commonwealth Fund or the HCFA, its directors, officers or staff. Dr Hughes is currently being supported by a National Primary Care Career Scientist Award from the Research and Development Office (Northern Ireland). The preliminary ideas presented here for the policy approach have been expanded by the team members of the Drug Team of this contract consisting of: Anne Hume, PharmD, Norma Owens, PharmD, David Gifford, MD, Steve Levenson, MD, Helen Deere-Powell, and Vince Mor PhD. We also acknowledge the hard work of two diligent graduate students Claudio Pedone, MD, MPH and Brian Quilliam, RPh., PhD, who assisted in the development and testing of the coronary heart disease quality indicator.

References

  1. 1.
    Census Bureau. US Census 1990Google Scholar
  2. 2.
    Butler RN. Population aging and health. BMJ 1997; 315: 1082–4PubMedCrossRefGoogle Scholar
  3. 3.
    Rhoades J. Nursing homes: Structure and selected characteristics, 1987 and 1996. Stat Bull Metrop Insura 1998; 79: 2–9Google Scholar
  4. 4.
    Ribbe MW, Ljunggren G, Steel K, et al. Nursing homes in 10 nations: a comparison between countries and settings. Age Ageing 1997; 26 Suppl. 2: 3–12PubMedCrossRefGoogle Scholar
  5. 5.
    Organisation for Economic Co-operation and Development (OECD). A caring world: the New Social Policy Agenda. Paris: OECD, 1999Google Scholar
  6. 6.
    Kemper P, Murtaugh CM. Lifetime use of nursing home care. N Engl J Med 1991; 324 (9): 595–600PubMedCrossRefGoogle Scholar
  7. 7.
    Spillman BC, Lubitz J. The effect of longevity on spending for acute and long-term care. N Engl J Med 2000; 342 (19): 1409–15PubMedCrossRefGoogle Scholar
  8. 8.
    Groom L, Avery AJ, Boot D, et al. The impact of nursing home patients on general practitioners’ workload. Br J Gen Pract 2000; 50 (455): 473–6PubMedGoogle Scholar
  9. 9.
    Institute of Medicine. Improving the quality of care in nursing homes. Washington, (DC): National Academy Press, 1986Google Scholar
  10. 10.
    OBRA (Omnibus Budget Reconciliation Act) 1987. US Congress. Public Law 101-508Google Scholar
  11. 11.
    Hawes C, Morris JN, Phillips CD, et al. Development of the nursing home Resident Assessment Instrument in the USA. Age Ageing 1997; 26 Suppl. 2: 19–25PubMedCrossRefGoogle Scholar
  12. 12.
    Elon R, Pawlson LG. The impact ofOBRAon medical practices within nursing facilities. J Am Geriatr Soc 1992; 40: 958–63PubMedGoogle Scholar
  13. 13.
    Fries BE, Hawes C, Morris JN, et al. Effect of the National Resident Assessment Instrument on selected health conditions and problems. J Am Geriatr Soc 1997; 45 (8): 994–1001PubMedGoogle Scholar
  14. 14.
    Phillips CD, Morris JN, Hawes C, et al. Association of the Resident Assessment Instrument (RAI) with changes in function, cognition, and psychosocial status. J Am Geriatr Soc 1997; 45 (8): 986–93PubMedGoogle Scholar
  15. 15.
    Hawes C, Mor V, Phillips CD, et al. The OBRA-87 nursing home regulations and implementation of theResidentAssessment Instrument: effects on process quality. J Am Geriatr Soc 1997; 45 (8): 977–85PubMedGoogle Scholar
  16. 16.
    Mor V, Intrator O, Fries BE, et al. Changes in hospitalization associated with introducing the Resident Assessment Instrument. J Am Geriatr Soc 1997; 45 (8): 1002–10PubMedGoogle Scholar
  17. 17.
    Ray WA. Improving quality of long term care. Med Care 2000; 38: 1151–3PubMedCrossRefGoogle Scholar
  18. 18.
    Royal Commission. With respect to old age: long-term carerights and responsibilities. A report by The Royal Commission on Long-term Care. London: The Stationery Office, 1999Google Scholar
  19. 19.
    Knight PV. Is the NHS guilty of ageism by not giving free personal care for some older people? BMJ 2001; 323: 337PubMedCrossRefGoogle Scholar
  20. 20.
    Cloutier-Fishera D, Joseph AE. Long-term care restructuring in ruralOntario: retrieving community service user and provider narratives. Soc Sci Med 2000; 50: 1037–45CrossRefGoogle Scholar
  21. 21.
    Anonymous, Medicare program; prospective payment system and consolidated billing for skilled nursing facilities—update. Health Care Financing Administration (HCFA), HHS. Final rule. Fed Regist 2000; 65: 46770–96Google Scholar
  22. 22.
    Fries BE, Schneider D, Foley WJ, et al. Refining a casemix measure for nursing homes: Resource Utilization Groups (RUG-III). Med Care 1994; 32: 668–85PubMedCrossRefGoogle Scholar
  23. 23.
    Baum C, Kennedy DL, Knapp DE, et al. Drug utilization in the US — 1986. Rockville (MD): Department of Health and Human Services, Food and Drug Administration, 1987Google Scholar
  24. 24.
    Lamy P. New dimensions and opportunities. Drug Intell Clin Pharm 1985; 19: 399–402PubMedGoogle Scholar
  25. 25.
    Hughes CM, Lapane KL, Mor V, et al. The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. J Am Geriatr Soc 2000; 48: 931–7PubMedGoogle Scholar
  26. 26.
    Davis DA, Thomson MA, Oxman AD, et al. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995; 274: 700–5PubMedCrossRefGoogle Scholar
  27. 27.
    Soumerai SB, McLaughlin TJ, Gurwitz JH, et al. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA 1998; 279: 1358–63PubMedCrossRefGoogle Scholar
  28. 28.
    Davis DA, Thomson MA, Oxman A, et al. Evidence for the effectiveness of CME: a review of 50 randomized controlled trials. JAMA 1992; 268: 1111–7PubMedCrossRefGoogle Scholar
  29. 29.
    Gifford DR, Mittman BS, Fink A, et al. Can a specialty society educate its members to think differently about clinical decisions? J Gen Intern Med 1996; 11: 664–72PubMedCrossRefGoogle Scholar
  30. 30.
    Dickersin K, Manheimer E. The Cochrane Collaboration: evaluation of health care and services using systematic reviews of the results of randomized controlled trials. Clin Obstet Gynecol 1998; 41: 315–31PubMedCrossRefGoogle Scholar
  31. 31.
    Avorn J, Soumerai SB, Everitt DE, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992; 327: 168–73PubMedCrossRefGoogle Scholar
  32. 32.
    Ray WA, Taylor JA, Meador KG, et al. Reducing antipsychotic drug use in nursing homes: a controlled trial of provider education. Arch Intern Med 1993; 153: 713–21PubMedCrossRefGoogle Scholar
  33. 33.
    Kane RL, Garrard J. Changing physician prescribing practices. JAMA 1994; 271: 393–4PubMedCrossRefGoogle Scholar
  34. 34.
    Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311–6PubMedCrossRefGoogle Scholar
  35. 35.
    Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events. JAMA 1998; 280: 1317–20PubMedCrossRefGoogle Scholar
  36. 36.
    Pestotnik SL, Classen DC, Evans RS, et al. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996; 124: 884–90PubMedGoogle Scholar
  37. 37.
    Evans RS, Pestotnik SL, Classen DC, et al. Acomputer-assisted management program for antibiotics and other anti-infective agents. N Engl J Med 1998; 338: 232–8PubMedCrossRefGoogle Scholar
  38. 38.
    Purves I, Nestor G, Williams K. Testing of PRODIGY continues. BMJ 1998; 316: 776–7PubMedCrossRefGoogle Scholar
  39. 39.
    Nightingale PG, Adu D, Richards NT, et al. Implementation of rules based computerised bedside prescribing and administration: intervention study. BMJ 2000; 320: 750–3PubMedCrossRefGoogle Scholar
  40. 40.
    Millman A, Lee N, Brooke A. ABC of medical computing: computers in general practice-I. BMJ 1995; 311: 800–2PubMedCrossRefGoogle Scholar
  41. 41.
    Schiff GD, Rucker TD. Computerized prescribing: building the electronic infrastructure for better medication usage. JAMA 1998; 279: 1024–9PubMedCrossRefGoogle Scholar
  42. 42.
    Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm 1994; 51: 772–7PubMedGoogle Scholar
  43. 43.
    Britton ML, Lurvey PL. Impact of medication profile review on prescribing in a general medicine clinic. Am J Hosp Pharm 1991; 48: 265–70PubMedGoogle Scholar
  44. 44.
    Lobas NH, Lepinski PW, Abramowitz PW. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory care clinic. Am JHosp Pharm 1992; 49: 1681–8Google Scholar
  45. 45.
    Windsor RA, Bailey WC, Richards JM, et al. Evaluation of the efficacy and cost-effectiveness of health education methods to increase medication adherence among adults with asthma. Am J Public Health 1990; 80 (12): 1519–21PubMedCrossRefGoogle Scholar
  46. 46.
    Monane M, Matthias DM, Nagle BA, et al. Improving prescribing patterns for the elderly through and online drug utilization review intervention: a system linking the physician, pharmacist, and computer. JAMA 1998; 280: 1249–52PubMedCrossRefGoogle Scholar
  47. 47.
    Tessier, EG. Evaluating drug therapy: principles and practices for long-term care providers. In: Tessier EG, Gaziano G, editors. Geriatric drug handbook for long-term care. Baltimore (MD): Williams and Wilkins, 1993: 165–174Google Scholar
  48. 48.
    Greco PJ, Eisenberg JM. Changing physicians’ practices. N Engl J Med 1993; 329 (17): 1271–3PubMedCrossRefGoogle Scholar
  49. 49.
    Health Care Financing Administration (HCFA). State Operations Manual. Washington, DC. Health Care Financing Administration (HCFA), 1995Google Scholar
  50. 50.
    Rovner BW, Edelman BA, Cox MP, et al. The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry 1992; 149: 1390–2PubMedGoogle Scholar
  51. 51.
    Semla TP, Palla K, Poddig B, et al. Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents. J Am Geriatr Soc 1994; 42: 648–52PubMedGoogle Scholar
  52. 52.
    Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA 1994; 271: 358–62PubMedCrossRefGoogle Scholar
  53. 53.
    Garrard J, Chen V, Dowd B. The impact of the 1987 Federal regulations on the use of psychotropic drugs in Minnesota nursing homes. Am J Public Health 1995; 85: 771–6PubMedCrossRefGoogle Scholar
  54. 54.
    Health Care Financing Administration (HCFA). State Operations Manual. Washington, DC.: Health Care Financing Administration (HCFA), 1999Google Scholar
  55. 55.
    Bernabei R, Gambassi G, Lapane KL, et al. Management of pain in elderly patients with cancer. JAMA 1998; 279: 1877–82PubMedCrossRefGoogle Scholar
  56. 56.
    Spooner JJ, Lapane KL, Hume AL, et al. Management of diabetes in long term care. J Clin Epidemiol; 2001; 54: 525–30PubMedCrossRefGoogle Scholar
  57. 57.
    Lapane KL, Barbour MM, VanHaaren A, et al. Antiischemic therapy in patients with coronary heart disease living in long term care. Pharmacotherapy; 1999; 19: 627–34PubMedCrossRefGoogle Scholar
  58. 58.
    Gambassi G, Forman DE, Lapane KL, et al. Management of heart failure among very old individuals living in long-term care: has the voice of trials spread? Am Heart J 2000; 139 (1): 85–93PubMedCrossRefGoogle Scholar
  59. 59.
    Aronow WS. Underutilization of aspirin in older patients with prior myocardial infarction at the time of admission to a nursing home. J Am Geriatr Soc 1998; 46 (5): 615–6PubMedGoogle Scholar
  60. 60.
    Quilliam BJ, Lapane KL. Pharmacologic treatment of stroke in long term care. Stroke 2001; 32: 1385–93PubMedCrossRefGoogle Scholar
  61. 61.
    Lapane KL, Fernandez H, Friedman J. Prevalence, clinical correlates and pharmacologic treatment of Parkinson’s disease patients living in long term care. Pharmacotherapy 1999; 19 (11): 1321–7PubMedCrossRefGoogle Scholar
  62. 62.
    Juul-Möller S, Edvardsson N, Jahnmatz B, et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 1992; 340: 1421–5Google Scholar
  63. 63.
    Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council’s General Practice Research Framework. Lancet 1998; 351: 233–41Google Scholar
  64. 64.
    Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death. myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists’ Collaboration. BMJ 1994; 308: 81–106Google Scholar
  65. 65.
    Bernabei R, Gambassi G, Lapane K, et al. Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. J Gerontol A Biol Sci Med Sci 1999; 54: M25–33PubMedCrossRefGoogle Scholar
  66. 66.
    Ridker PM, Manson JE, Gaziano JM, et al. Low-dose aspirin therapy for chronic stable angina: a randomized, placebo-controlled clinical trial. Ann Intern Med 1991; 114: 835–9PubMedGoogle Scholar
  67. 67.
    Marchiniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA 1998; 279: 1351–7CrossRefGoogle Scholar
  68. 68.
    Mehta RH, Das S, Tsai T, et al. Quality improvement initiative and its impact on the management of patients with acute myocardial infarction. Arch Intern Med 2000; 160: 3057–62PubMedCrossRefGoogle Scholar
  69. 69.
    Bradford WD, Chen J, Krumholz HM. Underutilisation of beta-blockers after acute myocardial infarction. Pharmacoeconomics 1999; 15: 257–68PubMedCrossRefGoogle Scholar
  70. 70.
    State of Managed Care Quality Report. Washington, DC: National Committee for Quality Assurance, 1999Google Scholar
  71. 71.
    Kane RL, Garrard J. Changing physician prescribing practices. JAMA 1994; 271: 393–4PubMedCrossRefGoogle Scholar
  72. 72.
    Royal College of Physicians, The Royal College of Nursing and the British Geriatrics Society in the UK (2000). The health and care of older people in care homes: a comprehensive interdisciplinary approach. London: Royal College of Physicians of London, 2000Google Scholar
  73. 73.
    Moss F. Quality in health care: a focus on the care of older people [editorial]. Qual Health Care 1997; 6: 117CrossRefGoogle Scholar
  74. 74.
    General Accounting Office. Nursing homes: additional steps needed to strengthen enforcement of federal quality standards. Report to Congressional Requesters. Washington, DC: General Accounting Office, 1999Google Scholar
  75. 75.
    Bowling A. Ageism in cardiology. BMJ 1999; 319: 1353–5PubMedCrossRefGoogle Scholar
  76. 76.
    Tonks A. Medicine must change to serve an ageing society. BMJ 1999; 319: 1450–1PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2002

Authors and Affiliations

  1. 1.Department of Community Health, Brown Medical SchoolBrown UniversityProvidenceUSA
  2. 2.School of PharmacyThe Queen’s University of BelfastBelfastNorthern Ireland

Personalised recommendations